Contemporary Approaches to the Diagnosis and Management of HCM
From batchUser
Agenda
- Moderator Introduction: Milind Desai, MD, MBA
- Case Presentation: Erika Hutt Centeno, MD
- Role of Echo, Strain and Stress Echo: Zoran Popovic, MD
- Role of Advanced Imaging: Bo Xu, MD
- Current State of Medical Therapies: Maran Thamilarasan, MD
- Septal Reduction Therapies: Nicholas Smedira, MD, MBA
- Principles of Afib and VT/VF Management in HCM: Mohamed Kanj, MD
- Emerging Therapies and Newer Data: Milind Desai, MD, MBA
- Presenter Panel Discussion
Learning Objectives:
- Identify cardiac imaging modalities for HCM to confirm the diagnosis, characterize the pathophysiology, and identify risk markers.
- Discuss optimizing care and challenging treatment decisions for patients with HCM.
- Recognize optimal opportunities for early interventions and the efficacy of septal reduction therapies performed at experienced HCM centers.
Complete CME process to claim your credit
Target Audience
This online series is designed for physicians, allied health practitioners and students interested in complex cardiovascular and thoracic conditions.
Accreditation Statement
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are Free of commercial bias.
The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Lars Svensson, MD, PhD, Hani Najm, MD, Christine Jellis, MD, Monisha Sudarshan, MD, Leslie Jurecko, Kathleen Breznai.
The following faculty has indicated that they may have a relationship, which in the context of their presentation(s) could be perceived as a potential conflict of interest: Eric E Roselli, MD, Activity Director: Abbott - Teaching and Speaking. Cook Medical - Teaching and Speaking. Cryolife, Inc. - Consulting. Edwards Lifesciences - Teaching and Speaking. LivaNova, PLC - Consulting, Teaching and Speaking. Medtronic - Consulting. Terumo - Teaching and Speaking. W.L. Gore & Associates - Consulting. Milind Desai, MD: Medtronic - Research / Independent Contractor. Myokardia - Research / Independent Contractor. Silence Therapeutics - Research / Independent Contractor. Mohamed Kanj, MD: Boston Scientific Corporation - Teaching and Speaking.
For further information about this activity, contact Katie Breznai at breznak@ccf.org
- Tags
-